COVID-19 antiviral treatment: Molnupiravir
Information for those who have been prescribed Molnupiravir.
Documents
Details
The NHS is offering new antibody and antiviral treatments to people with coronavirus (COVID-19) who are at highest risk of becoming seriously ill.
This document includes information for those who have been prescribed Molnupiravir including how long to take the medicines for, what to do if you are pregnant or breastfeeding, and how to report side effects.
Paper copies of this leaflet are available free to order or download in the following languages:
English, Albanian, Arabic, Bengali, Bulgarian, Chinese (simplified), Chinese (traditional, Cantonese), Estonian, Farsi, French, Greek, Gujarati, Hindi, Latvian, Lithuanian, Panjabi, Pashto, Polish, Portuguese, Romanian, Romany, Russian, Somali, Spanish, Tagalog, Turkish, Twi, Ukrainian, Urdu and Yiddish.
An English large print version is available to order.
A Braille version of this leaflet is available to order.
An audio version of this leaflet is available to download.
A British sign language (BSL) video of this guide is available to view or download.
Find public health resources
Find this resource on www.gov.uk/publichealthresources where you can view, download or order resources free of charge.
Alternatively, you can get in touch by phone or email.
Please have the product code with you when you contact us.
Email publichealthresources@ukhsa.gov.uk
Contact form https://www.gov.uk/gui...
Telephone: 0300 123 1002
Monday to Friday, 9am to 5:30pm
Updates to this page
-
Added links to translations and alternative formats.
-
Added British Sign Language video link.
-
First published.